Guardian Pharmacy Services, Inc.
NYSE:GRDNMedical - Distribution
+$0.17 today
- Market cap
- $3.09B
- Beta
- 0.08
- P/E (TTM)
- 52.0
- EPS (TTM)
- $0.84
Volume 0.45M
Average 0.48M
GRDN Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Guardian Pharmacy Services, Inc.NYSE: GRDN
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue dips below year-ago levels
Q2 FY2026 cost of revenue of $271.72M fell 1.6% year over year, behind the +7.6% change in trailing-twelve-month cost of revenue. Sequentially, it rose 4.4% from the prior quarter. Over 3 fiscal years it compounded at +17.3% a year.
Context
- Cost of revenue amounted to 80.5% of revenue in FY2025, up 0.4 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -1.6% toward the trailing-twelve-month pace of +7.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.17B USD
- Year-over-year change
- +18.6%
- 4-year CAGR
- +16.6%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.17B | +18.6% |
| FY2024 | 2024-12-31 | 984.04M | +17.4% |
| FY2023 | 2023-12-31 | 837.88M | +15.9% |
| FY2022 | 2022-12-31 | 723.04M | +14.6% |
| FY2021 | 2021-12-31 | 630.81M | — |
Cost of Revenue vs competitors
How GRDN compares with its peers on the latest reported figures
- GRDN's LTM Jun 2026 cost of revenue of $1.15B is the 3rd highest of the 11 companies compared; the peer median is $146.57M.
- Its year-over-year change of +7.6% is the 4th highest of 10, against a peer median of -0.3%.
- Cost of revenue amounts to 78.4% of revenue for GRDN, versus a peer median of 45.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.53B | +7.1% | -1.4% | 78.0% | |
| LTM Mar 2026 | $1.46B | -0.3% | +3.1% | 55.0% | |
GRDNGuardian Pharmacy Services, Inc. | LTM Jun 2026 | $1.15B | +7.6% | +17.3% | 78.4% |
| LTM Sep 2026 | $1.08B | +16.9% | +10.3% | 68.0% | |
| LTM Sep 2026 | $218.63M | +17.8% | +12.1% | 47.6% | |
| LTM Sep 2026 | $173.93M | -13.0% | +18.2% | 28.1% | |
| LTM Mar 2026 | $119.22M | +28.3% | +43.4% | 37.0% | |
| LTM Jun 2026 | $19.21M | -63.8% | -29.5% | 16.0% | |
| LTM Jun 2026 | $10.3M | -1.0% | — | 6.1% | |
| LTM Mar 2026 | $9.91M | -79.7% | +34.1% | 45.9% | |
| LTM Sep 2026 | $590K | — | — | — | |
| Peer median (excluding GRDN) | $146.57M | -0.3% | +11.2% | 45.9% | |
Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 792.07M | 908.91M | 1.05B | 1.23B | 1.45B |
| Cost of Revenue | 630.81M | 723.04M | 837.88M | 984.04M | 1.17B |
| Gross Profit | 161.27M | 185.87M | 208.31M | 244.37M | 282.04M |
| Gross Margin | 20.4% | 20.4% | 19.9% | 19.9% | 19.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 131.12M | 133.88M | 167.36M | 307.29M | 193.13M |
| Operating Expenses | 131.12M | 133.88M | 167.36M | 307.29M | 193.13M |
| Depreciation & Amortization | 16.53M | 16.56M | 18.23M | 19.77M | 22.34M |
| EBITDA | 46.49M | 68.15M | 58.81M | (43.43M) | 96.42M |
| EBITDA Margin | 5.9% | 7.5% | 5.6% | -3.5% | 6.7% |
| Operating Income | 30.15M | 51.99M | 40.95M | (62.92M) | 88.91M |
| Operating Margin | 3.8% | 5.7% | 3.9% | -5.1% | 6.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.64M | 1.93M | 2.86M | 3.28M | 665K |
| Other Income / Expenses | (1.82M) | (2.33M) | (3.23M) | (3.56M) | (15.49M) |
| Income Before Tax | 28.33M | 49.66M | 37.72M | (66.48M) | 73.42M |
| Pre-Tax Margin | 3.6% | 5.5% | 3.6% | -5.4% | 5.1% |
| Income Tax Expense | 0 | 0 | 0 | 4.56M | 24.47M |
| Net Income | 16.31M | 35.42M | 23.9M | (87.29M) | 49.22M |
| Net Margin | 2.1% | 3.9% | 2.3% | -7.1% | 3.4% |
| EPS (Basic) | 0.27 | 0.58 | 0.39 | (1.77) | 0.79 |
| EPS (Diluted) | 0.27 | 0.58 | 0.39 | (1.77) | 0.78 |
| Weighted Avg Shares | 60.84M | 60.84M | 60.84M | 62.01M | 62.39M |
| Weighted Avg Shares (Diluted) | 60.84M | 60.84M | 60.84M | 62.01M | 63.3M |
Guardian Pharmacy Services, Inc.
NYSE:GRDN
Intrinsic Alpha fair value
Locked
Current Price
$48.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.